文献速递肾移植

一种用于评估肾移植活检的简易分子工具

A Simple Molecular Tool for the Assessment of Kidney Transplant Biopsies.
PubMed 文献 · Clin J Am Soc Nephrol · 2023-03-08

本研究基于两个中心的220例肾移植活检(52例抗体介导排斥、51例T细胞介导排斥、117例无排斥对照),开发并验证了一种17基因RT-MLPA检测联合支持向量机分类器用于排斥诊断与分类。分类器训练集和测试集准确率分别为0.84和0.83,抗体介导排斥的曲线下面积为0.96。

要点

  • 17基因RT-MLPA检测可对石蜡包埋肾移植活检进行排斥分类,总体准确预测比为0.83。
  • 测试队列中抗体介导排斥、T细胞介导排斥和对照的F1分数分别为0.88、0.86和0.69。
  • RT-MLPA与Nanostring基因表达水平相关(r=0.68,P<0.001),81%样本获得等效基因表达谱。

核心结论

  • 针对福尔马林固定石蜡包埋肾移植活检开发的17基因RT-MLPA检测,以0.83的总体准确预测比对肾移植排斥进行分类。

研究设计与样本

  • 回顾性队列研究,纳入两个中心的220例肾移植活检,包括52例抗体介导排斥、51例T细胞介导排斥和117例无排斥对照。
  • 基于相关病理生理通路确定17基因组合,开发支持向量机分类器。
  • 对109例活检子集同时使用Nanostring Banff人类器官移植组合进行评估以比较两种检测。

主要发现

  • 支持向量机分类器训练集和测试集准确率分别为0.84和0.83。
  • 测试队列中抗体介导排斥、T细胞介导排斥和对照的F1分数分别为0.88、0.86和0.69。
  • 受试者工作特征曲线下面积分别为抗体介导排斥0.96、T细胞介导排斥0.89、对照0.91,加权平均0.94。
  • 分类器性能在抗体介导排斥诊断中最高,正确预测率为94%,对照活检为88%,T细胞介导排斥活检为60%。
  • RT-MLPA与Nanostring评估的基因表达水平相关(r=0.68,P<0.001),81%的样本两种检测获得等效基因表达谱。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Banff Classification for Allograft Pathology recommendations for the diagnosis of kidney transplant rejection includes molecular assessment of the transplant biopsy. However, implementation of molecular tools in clinical practice is still limited, partly due to the required expertise and financial investment. The reverse transcriptase multiplex ligation-dependent probe amplification (RT-MLPA) assay is a simple, rapid, and inexpensive assay that permits simultaneous evaluation of a restricted gene panel using paraffin-embedded tissue blocks. The aim of this study was to develop and validate a RT-MLPA assay for diagnosis and classification of rejection. METHODS: A retrospective cohort of 220 kidney transplant biopsies from two centers, which included 52 antibody-mediated rejection, 51 T-cell-mediated rejection, and 117 no-rejection controls, was assessed. A 17-gene panel was identified on the basis of relevant pathophysiological pathways. A support vector machine classifier was developed. A subset of 109 biopsies was also assessed using the Nanostring Banff Human Organ Transplant panel to compare the two assays. RESULTS: The support vector machine classifier train and test accuracy scores were 0.84 and 0.83, respectively. In the test cohort, the F1 score for antibody-mediated rejection, T-cell-mediated rejection, and control were 0.88, 0.86, and 0.69, respectively. Using receiver-operating characteristic curves, the area under the curve for class predictions was 0.96, 0.89, and 0.91, respectively, with a weighted average at 0.94. Classifiers' performances were highest for antibody-mediated rejection diagnosis with 94% correct predictions, compared with 88% correct predictions for control biopsies and 60% for T-cell-mediated rejection biopsies. Gene expression levels assessed by RT-MLPA and Nanostring were correlated: r = 0.68, P < 0.001. Equivalent gene expression profiles were obtained with both assays in 81% of the samples. CONCLUSIONS: The 17-gene panel RT-MLPA assay, developed here for formalin-fixed paraffin-embedded kidney transplant biopsies, classified kidney transplant rejection with an overall accurate prediction ratio of 0.83. PODCAST: This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/CJASN/2023_04_10_CJN10100822.mp3.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. de Nattes T, Beadle J, Toulza F, et al. A Simple Molecular Tool for the Assessment of Kidney Transplant Biopsies. Clin J Am Soc Nephrol. 2023. PMID: 36723289. doi:10.2215/CJN.0000000000000100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。